Biagro Western Sales, Inc. v. Grow More, Inc.

423 F.3d 1296, 76 U.S.P.Q. 2d (BNA) 1347, 2005 U.S. App. LEXIS 19680, 2005 WL 2207685
CourtCourt of Appeals for the Federal Circuit
DecidedSeptember 13, 2005
Docket2004-1414
StatusPublished
Cited by53 cases

This text of 423 F.3d 1296 (Biagro Western Sales, Inc. v. Grow More, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Biagro Western Sales, Inc. v. Grow More, Inc., 423 F.3d 1296, 76 U.S.P.Q. 2d (BNA) 1347, 2005 U.S. App. LEXIS 19680, 2005 WL 2207685 (Fed. Cir. 2005).

Opinion

PLAGER, Senior Circuit Judge.

In this patent infringement case, Biagro Western Sales, Inc. (“Biagro”) and The Regents of the University of California (“The Regents”) sued Grow More, Inc. (“Grow More”) in the United States District Court for the Eastern District of California. At issue is U.S. Patent No. 5,830,255 (“the ’255 patent”), which is entitled “Formulation of Phosphorus Fertilizer for Plants.” The Regents are the assignee and Biagro is the exclusive licensee of the ’255 patent.

On cross-motions for summary judgment, the trial court held that Grow More did not literally infringe the claims of the patent. The trial court further held that there was no infringement under the doctrine of equivalents. Judgment was awarded to Grow More. We affirm the judgment of the trial court.

BACKGROUND

The United States Patent and Trademark Office (“PTO”) issued the ’255 patent on November 3, 1998. At the request of The Regents, to whom the patent had been assigned, the PTO undertook a reexamination and issued a reexamination certificate on July 11, 2000. As a result of the reexamination, all of the independent claims were amended by adding a limitation, originally in several dependent claims, relating to the amount of phosphorous-containing acid or salt thereof in the fertilizer formulation.

After reexamination, claim 1, representative of the independent claims of the ’255 patent, read:

A concentrated phosphorus fertilizer comprising a buffered composition comprising at least one phosphorous-containing acid or salt thereof such that when said composition is diluted with water having a pH of about 6.5 at a ratio of about 1 part fertilizer to about 40 parts water, there is formed a substantially fully solubilized use-dilution fertilizer having a foliage-acceptable pH for phosphorus uptake and wherein said phosphorous-containing acid or salt thereof is present in an amount of about SO to about JpO weight percent.

The emphasized language was added during reexamination to distinguish the claimed invention over prior art. That added limitation is the focus of the dispute in this case.

The term “phosphorous” is an adjectival modifier describing certain compounds containing the element phosphorus (P). In the patent, the term “phosphorous-containing acid” is used to refer to a group of acids that includes phosphorous acid (H3 P03), among other acids. ’255 patent, col. 3, 11. 56-60. The patent also states that the formulations in the patent are expressed in terms of weight-to-volume, instead of weight-to-weight, and therefore the term “weight percent” as used in the claims refers to a weight-to-volume percentage. Id. at col. 6,1. 67.

Grow More’s accused product is a phosphorus fertilizer named Phos-Pro. Phos- *1300 Pro is made by mixing phosphorous acid (H3P03) with potassium hydroxide (KOH) and water. The reaction results in a solution containing two phosphorous acid salts — dipotassium monohydrogen phos-phite (K2HP03) and potassium dihydrogen phosphite (KH2P03), referred to in abbreviated form as dipotassium phosphite and potassium phosphite. A third phosphite, tripotassium phosphite (K3P03), is present in trace amounts. However, and importantly, the final Phos-Pro product does not contain any phosphorous acid as such.

Biagro, as the exclusive licensee of the ’255 patent, filed this patent infringement suit against Grow More in July 2000, shortly after the PTO completed reexamination of the patent. Grow More filed counterclaims for declaratory judgments of non-infringement and invalidity and for unfair competition under California state law. The Regents were eventually joined as a plaintiff. 1

The parties filed cross-motions for summary judgment on the question of infringement. At issue was the meaning of the added limitation specifying that in the claimed fertilizer composition there was a “phosphorous-containing acid or salt thereof ... present in an amount of about 30 to about 40 weight percent.” Biagro argued that the limitation can be met in an accused product by calculating a ‘chemical equivalent’ amount of phosphorous-containing acid, based on the chemical composition of the fertilizer. In the case of the accused Grow More fertilizer, that would be the same as the amount of phosphorous-containing acid used in the initial manufacture of the product. Grow More argued to the contrary that the limitation referred to the amount of phosphorous-containing acid or salt actually present in the final fertilizer product. The trial court construed the limitation as Grow More proposed and, since the Grow More final product contained no phosphorous-containing acid, held for Grow More on that issue.

The trial court concluded further that, with regard to the content of acid salts in the fertilizer, a fertilizer containing two or more phosphorous-containing salts comes within the literal scope of the claim only if the aggregate amount of such salts is between about 30 and about 40 weight percent. Based on tests and calculations made by Biagro’s expert, the concentration of potassium phosphite in Phos-Pro is 40.3%, and the concentration of dipotassi-um phosphite is 19.0%. Grow More’s calculations indicated the phosphite content to be slightly higher based on a different specific gravity used to convert weight-to-weight percentages to weight-to-volume percentages. According to Grow More’s calculations, the weight-to-volume percentages are 42.2% for potassium phosphite and 19.9% for dipotassium phosphite. Thus the total phosphite concentration in the accused product is between 59.3% and 62.1%, depending on which party’s calculations are used.

Since the aggregate concentration of the two phosphites in the accused product is at least 59.3% weight percent, well outside the claimed range and thus not literally infringing, the question was whether the amount of salts could be considered infringing under the doctrine of equivalents, that is, whether 60(+/-)% could be considered the equivalent of about 30 to about 40%. The trial court chose not to address that question, but instead held for Grow More on the ground that, in light of the amended claims, prosecution history estop-pel acted as a complete bar to a claim of *1301 infringement under the doctrine of equivalents according to this court’s en banc decision in Festo Corp. v. Shoketsu Kinzoku Kogyo Kabushiki Co., 234 F.3d 558 (Fed.Cir.2000) (en banc) (“Festo I”), the law in effect at the time. The trial court granted judgment for Grow More. Biagro W. Sales, Inc. v. Grow More, Inc., No. CV-F-00-6105 (E.D.Cal. Oct. 18, 2001).

Biagro filed two motions for reconsideration directed to the issue of whether a proper claim construction should permit use of the chemical equivalent analysis' The trial court denied both of these motions for reconsideration. Biagro W. Sales, Inc. v. Grow More, Inc., No. CV-F-00-6105 (E.D.Cal. Aug. 15, 2002); Biagro W. Sales, Inc. v. Grow More, Inc., No. CV-F-00-6105 (E.D.Cal. Apr. 9, 2003).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Arbmetrics, LLC v. Dexcom Inc.
S.D. California, 2019
Eli Lilly and Company v. Hospira, Inc.
933 F.3d 1320 (Federal Circuit, 2019)
Ajinomoto Co. v. Int'l Trade Comm'n
932 F.3d 1342 (Federal Circuit, 2019)
Ferring B.V. v. Serenity Pharm., LLC
356 F. Supp. 3d 353 (S.D. Illinois, 2019)
Pharma Tech Solutions Inc. v. Lifescan Inc.
348 F. Supp. 3d 1076 (D. Nevada, 2018)
UCB, Inc. v. Yeda Research & Development Co.
117 F. Supp. 3d 755 (E.D. Virginia, 2015)
California Institute of Technology v. Hughes Communications Inc.
35 F. Supp. 3d 1176 (C.D. California, 2014)
3m Innovative Properties v. Tredegar Corporation
725 F.3d 1315 (Federal Circuit, 2013)
Sandisk Corp. v. Kingston Technology Co., Inc.
695 F.3d 1348 (Federal Circuit, 2012)
Paone v. Microsoft Corp.
881 F. Supp. 2d 386 (E.D. New York, 2012)
CBT Flint Partners, LLC v. Return Path, Inc.
870 F. Supp. 2d 1369 (N.D. Georgia, 2012)
Stern v. Sequal Technologies, Inc.
840 F. Supp. 2d 1260 (W.D. Washington, 2012)
Touchtunes Music Corp. v. Rowe International Corp.
727 F. Supp. 2d 226 (S.D. New York, 2010)
Duramed Pharmaceuticals, Inc. v. Paddock Laboratories, Inc.
715 F. Supp. 2d 552 (S.D. New York, 2010)

Cite This Page — Counsel Stack

Bluebook (online)
423 F.3d 1296, 76 U.S.P.Q. 2d (BNA) 1347, 2005 U.S. App. LEXIS 19680, 2005 WL 2207685, Counsel Stack Legal Research, https://law.counselstack.com/opinion/biagro-western-sales-inc-v-grow-more-inc-cafc-2005.